Carlos Alban, EVP, Commercial Operations at AbbVie Inc. (ABBV), sold 18,201 shares at $50.09 ($924K) on 2014-03-03, disclosed to the SEC on 2014-03-04.
Scheduled sale ($924k) by EVP, Commercial Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.91 | 15,319 | $780K | 84.4% |
| 2 | $50.09 | 282 | $14K | 1.5% |
| 3 | $50.09 | 400 | $20K | 2.2% |
| 4 | $50.09 | 600 | $30K | 3.3% |
| 5 | $50.09 | 1,600 | $80K | 8.7% |
| Total | $50.78 avg | 18,201 |
| $924K |
| 100% |
| Filing → |
| ABBV | SELL | 2018-03-02 | $19.1M | — | Filing → |
| ABBV | SELL | 2017-06-15 | $3.2M | — | Filing → |
| ABBV | SELL | 2017-05-08 | $2.9M | — | Filing → |